K-PAX manufactures immune support products. It offers its products for supporting adrenal fatigue and immune system; and teeth, bone, and immune health, as well as treating sore throats and sinus infections. Its products category includes heart health, GI support, joints and bones, men's health, kid's health, women's health, multivitamins, and coughs and colds. The company serves its customers through retail outlets in the United States. K-PAX is based in Mill Valley, California.

DR Healthcare Espana SL operates as a biomedical company that specializes in biofunctionalism (functional and genomic biology). The firm engages in the development, manufacture, and commercialization of therapeutic products. It offers DiAmine Oxidase(DAO)-based solutions for migraine pain management. The company also conducts biomedical research on metabolic diseases and DAO deficiency, their causes, treatment, and clinical course. DR Healthcare Espana was founded by Juan Jose Duelo Riu and Carlos Duelo in May 2008 and is headquartered in Barcelona, Spain.

Neuro-Biotech Corp. engages in the field of neuroscience. It develops and distributes analytical diagnostic products such as diagnostic blood tests, which are designed to facilitate early diagnosis and monitoring. The company was founded on July 26, 1990 and is headquartered in Basel, Switzerland.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Elan Pharma International Ltd., a subsidiary of Perrigo Co. Plc, is a company headquartered in South San Francisco, CA, that develops, manufactures and distributes pharmaceutical products.

Chronos Therapeutics’ drug development scheme focuses in two main areas: - Repositioning FDA approved drugs. - Screening, discovery and development of novel proprietary drug candidates. Current Targets - Diseases of Ageing: Osteoporosis, Cancer and Sarcopenia. - Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, ALS and Orphan Synucleopathies. Chronos Therapeutics’ research is successfully advancing from pre-clinical stages of development for age-related disease treatments to clinical development. Chronos' pioneering drug discovery and development platform the Chronoscreen has enabled the company to quickly gain proprietary positions in the regulation of cellular chronological lifespan. Some of the most exciting and effective therapeutic approaches of the future will utilize our understanding of the biological programming of life-span and ageing that take place in every cell of our body. Harnessing this knowledge will lead to novel treatments for age related diseases such as Alzheimer's Disease, Diabetes, Cancer and Osteoporosis.

JPT is an ISO 9001 certified provider of innovative peptide products and services and a partner for research projects focusing on applications in Immunotherapy, Immunology, Proteomics & Enzyme Profiling. JPT's head office and production sites are located in Berlin, Germany. Together with its partner company JPT Peptide Technologies Inc. based in Acton, near Boston, Massachusetts, JPT is serving a worldwide customer base in the pharmaceutical and biotechnology industries, as well as researchers in universities, governmental and non-profit organizations. Over the past decade, JPT has developed a portfolio of proprietary technologies and a series of unique products and services which support research efforts in proteomics, all development phases of novel vaccines or immunotherapies and peptides based drug discovery. JPT has a work force of >100 highly trained and skilled employees. 30 of our co-workers hold a university degree and 20 have a PhD in natural sciences. Over the last 15 years our team has built a substantial know-how in all areas of peptide applications. We take pride not only in the superior quality of our products and the efficient certified quality management system but also in our competent customer service and swift response.

IGC Pharma, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment is involved in the rental of heavy construction equipment, execution of construction contracts, and purchase and resale of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

China Food Peptide (Beijing) Biotechnology Co., Ltd., established on 2003-10-23, Business scope includes technology development,Technical Services,technical consulting;Import and export,Technology Import and Export,Agent import and export;Agricultural Science Research and Experimental Development;Sales instrumentation,Chemical Products(Free of chemical hazards),daily necessities,feed,medical instrumentsIkind,medical instrumentsIIkind;Production and processing of finalized packaged food(Limited to branch operations);sell food;Sales No.IIIclass of medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Sales No.IIIClass medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Elan Corporation, plc is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan was incorporated as a private limited company in Ireland in December 1969 and became a public limited company in January 1984. Elan shares trade on the New York and Irish Stock Exchanges.

Sichuan Credit Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of products related to central nervous system. Its products include capsules, tablets, freeze-dried powder injections, water injections, anti-tumor solid preparations, and traditional Chinese medicines. The company was founded on April 20, 2000 and is headquartered in Luzhou, China.

Mizkan Co., Ltd. manufactures condiments and other food seasonings. Its products include vinegar, citrus seasoning, sweet seasoning, cooking wine, mustard, dressing, soup base, sauce, and fermented soybeans. The company is headquartered in Handa, Japan.

Unix Electronics Co. Ltd. is a South Korean private company. The firm manufactures hairdryer, beauty products and other household equipments.

Botamedi provides marine phytochemical therapeutics.